top of page

Providing treatment
to the most neglected.

Experience the power of controlled local heat application and join us in our mission to make safer treatment accessible for everyone.


Addressing a crucial need, our device CLARA offers a

non-invasive alternative treatment for Cutaneous Leishmaniasis

What is cutaneous Leishmaniasis?

Cutaneous Leishmaniasis is a neglected tropical disease that affects millions worldwide. This condition, caused by parasites transmitted through sandfly bites, results in painful skin ulcers and can lead to severe scarring and disability. Despite its widespread impact, it remains under-researched and overlooked in the global health landscape.

The Risks of Traditional  Treatments

Drug injections have been the frontline treatment for Cutaneous Leishmaniasis (CL). However, these treatments can present serious risks. They're not only invasive but can cause severe side effects, including muscle pain, heart complications, and potential damage to the liver or kidneys. Furthermore, the considerable pain associated with the injections and the lengthy treatment duration often deter patients from pursuing this treatment option.


Unseen Scars: The Stigma of CL

Affecting millions in rural and poverty-stricken areas, this neglected tropical disease often results in visible lesions, leading to stigma and ostracization. People affected by CL carry not just the physical pain but also the burden of social exclusion, influencing their self-esteem and their place within their communities.

Radiofrequency: Reshaping
CL Treatment

CLARA leverages the proven technology of radiofrequency heating to offer an effective solution for Cutaneous Leishmaniasis.


We are supported by

DNDi_Logo_EN_Full Colour_margins.png
Innosuisse_Logo_supported_Initial_Coaching_rgb_EN (1).png
bottom of page